谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Regorafenib Dose Optimization Study (redos): A Phase II Randomized Study of Lower Starting Dose Regorafenib Compared to Standard Dose Regorafenib in Patients with Refractory Metastatic Colorectal Cancer (Mcrc).

Tanios S. Bekaii-Saab,Fang-Shu Ou,Kristen Keon Ciombor,Mohamed I. Farhat,Jeffrey J. Kirshner,James A. Knost,Daniel M. Anderson,Gamini S. Soori,Patrick Mckay Boland,Donald B. Wender,Rodwige J. Desnoyers,Daniel J. Sargent,Axel Grothey

Journal of clinical oncology（2016）

引用 3|浏览64
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要